Johnson & Johnson (BCBA:JNJ)

Market Cap	652.92T
Revenue (ttm)	107.61T
Net Income (ttm)	26.91T
Shares Out	n/a
EPS (ttm)	11,083.28
PE Ratio	24.27
Forward PE	17.45
Dividend	251.45 (1.35%)
Ex-Dividend Date	Aug 26, 2025

Volume	7,473
Average Volume	21,784
Open	19,800
Previous Close	19,610
Day's Range	18,620 - 19,840
52-Week Range	10,425 - 19,840
Beta	0.39
RSI	56.03
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD